We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+7.33%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.44B
AUM Growth
+$259M
(+4.2%)
Cap. Flow
+$227M
Cap. Flow
% of AUM
3.52%
Top 10 Holdings %
Top 10 Hldgs %
34.31%
Holding
1,318
New
461
Increased
339
Reduced
236
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$330M |
| 2 |
Brookdale Senior Living
BKD
|
+$93.7M |
| 3 |
Tenet Healthcare
THC
|
+$85.2M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$70.6M |
| 5 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$64.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$206M |
| 2 |
CVS Health
CVS
|
+$122M |
| 3 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$102M |
| 4 |
McKesson
MCK
|
+$80.6M |
| 5 |
Pacira BioSciences
PCRX
|
+$45.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.08% |
| 2 | Miscellaneous | 9.89% |
| 3 | Energy | 6.47% |
| 4 | Consumer Discretionary | 5.67% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Air Products & Chemicals
APD
$64.7B
| $3.52M | 0.05% |
+29,617
| New | +$3.3M |
|
277
Lennar Class A
LEN
$19.3B
| $3.52M | 0.05% |
+88,129
| New | +$3.34M |
|
|
HNSN
278
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
| $3.47M | 0.05% |
265,000
-77,604
| -23% | -$1.35M |
|
|
LLL
279
DELISTED
L3 Technologies, Inc.
LLL
| $3.46M | 0.05% |
+28,695
| New | +$3.41M |
|
|
TRIB
280
Trinity Biotech
TRIB
$5.96M
| $3.46M | 0.05% |
+1,000
| New | +$3.56M |
|
|
QTNT
281
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $3.45M | 0.05% |
+10,357
| New | +$3.24M |
|
282
Fastenal
FAST
$56.7B
| $3.42M | 0.05% |
+276,684
| New | +$3.42M |
|
283
AutoZone
AZO
$46.7B
| $3.4M | 0.05% |
6,337
+5,896
| +1,337% | +$3.12M |
|
284
Arthur J. Gallagher & Co
AJG
$63.6B
| $3.35M | 0.05% |
+71,889
| New | +$3.28M |
|
|
EXPR
285
DELISTED
Express, Inc.
EXPR
| $3.35M | 0.05% |
+9,836
| New | +$2.94M |
|
286
Philip Morris
PM
$303B
| $3.34M | 0.05% |
+39,642
| New | +$3.41M |
|
287
Jack in the Box
JACK
$261M
| $3.34M | 0.05% |
+55,830
| New | +$3.2M |
|
288
RPC Inc
RES
$1.37B
| $3.33M | 0.05% |
141,620
-246,597
| -64% | -$5.42M |
|
289
Oneok
OKE
$59.7B
| $3.29M | 0.05% |
48,325
+30,355
| +169% | +$1.92M |
|
290
Brown & Brown
BRO
$22.5B
| $3.2M | 0.05% |
+208,640
| New | +$3.14M |
|
291
Adobe
ADBE
$102B
| $3.18M | 0.05% |
+43,993
| New | +$2.84M |
|
292
Beazer Homes USA
BZH
$890M
| $3.18M | 0.05% |
151,500
+1,500
| +1% | +$29.2K |
|
293
Morgan Stanley
MS
$324B
| $3.15M | 0.05% |
97,384
+59,416
| +156% | +$1.83M |
|
|
BHI
294
DELISTED
Baker Hughes
BHI
| $3.15M | 0.05% |
42,269
-11,327
| -21% | -$788K |
|
295
Henry Schein
HSIC
$9.75B
| $3.13M | 0.05% |
67,154
-87,975
| -57% | -$4.02M |
|
|
CNL
296
DELISTED
CLECO CRP (HOLDING CO)
CNL
| $3.09M | 0.05% |
+52,439
| New | +$2.73M |
|
297
Valero Energy
VLO
$114B
| $3.09M | 0.05% |
61,620
+50,739
| +466% | +$2.8M |
|
|
KS
298
DELISTED
KapStone Paper and Pack Corp.
KS
| $3.08M | 0.05% |
92,929
+74,522
| +405% | +$2.12M |
|
|
MRD
299
DELISTED
MEMORIAL RESOURCE DEV CORP COM STK (DE)
MRD
| $3.06M | 0.05% |
+125,821
| New | +$3.03M |
|
300
Rayonier
RYN
$6.08B
| $3.04M | 0.05% |
+94,189
| New | +$2.95M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Visium Asset Management held 1,318 positions worth $6.44B, up 4.2% from $6.18B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Visium Asset Management deployed $227M of net new capital in Q2 2014, opening 461 new positions and adding to 339 existing holdings. Its largest new stake was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 56% a quarter earlier, followed by Miscellaneous and Energy.
On the sell side, the largest reduction was Bausch Health, an estimated $206M trimmed.
- Visium Asset Management's largest Q2 2014 buy was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
- Visium Asset Management added most to Allergan Inc in Q2 2014, an estimated $330M increase.
- Visium Asset Management's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $206M.
- Visium Asset Management fully exited QUESTCOR PHARMA INC in Q2 2014, selling an estimated $34M.
- Visium Asset Management's ten largest holdings make up 34% of its $6.44B portfolio in Q2 2014.
- Visium Asset Management opened 461 new positions and closed 232 in Q2 2014.
- Visium Asset Management's portfolio value rose 4.2% quarter-over-quarter to $6.44B.
Based on Visium Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.